- Advertisement -
The Serum Institute of India (SII) has developed the first indigenous vaccine. It will be launched next week said Union Health Minister Dr. Harsh Vardhan next week and then soon it will be available in the domestic market next week. According to information from the source, this vaccine will be more affordable. Currently, a vaccine produced by two foreign companies, Pfizer and GlaxoSmithkline, is used for pneumonia.
Read also: How to get rid of deer
The Indian drug regulator gave the market approval to the serum institute for the pneumococcal polysaccharide conjugate vaccine in July. The drug regulator took this decision after reviewing the clinical trial data for the first, second and third stages by the institute. This trial was done in India and the African country of Gambia.
The country’s first pneumonia vaccine will be used as an active immunization against pneumonia and invasive diseases (fast-spreading diseases) in children caused by Streptococcus pneumoniae.
Historical achievement amid corona pandemic
In a letter to Union Health Minister Harsh Vardhan, Additional Director (Government and Regulatory Affairs) of Serum Institute, Prakash Kumar Singh, wrote that Prime Minister Narendra Modi’s ambitious plan moving towards self-reliant India, Serum Institute amidst another historic milestone amid Corona pandemic has achieved.
Read also: Recreate a Viral Activity Without Copying Its Hidden Work
Also Check: How Exercising and Mental Health Help in Stress Management
Annually more than 1 lakh children die at a young age
According to UNICEF data, every year more than one lakh children in India die from pneumococcal diseases at the age of five. Since pneumonia is a respiratory disease, giving PCV to children is very important in the midst of the corona pandemic. Let me tell you that Coronavirus also causes respiratory problems.
Read also: World Day against Child Labour 2027 Theme, Quotes, Poster, Wishes, Images, and Drawing
- Advertisement -
Background and Overview
Understanding the context behind Serum Institute's large breakthrough in preventing pneumonia, prepared first indigenous vaccine helps provide a complete picture of why it has attracted public attention. Over recent months, interest has grown steadily as more details and discussions emerged across various media channels. Keeping up with verified facts ensures readers get an authentic and balanced perspective on the topic.
Key Highlights and Essential Details
Several notable points stand out when looking at the developments surrounding this topic:
- Core Details: The primary factors driving interest and why audiences continue to follow updates closely.
- Verified Insights: Cross-checked information that clarifies common questions and separates facts from rumors.
- Audience Impact: How followers, fans, and observers have responded to the latest announcements and appearances.
Final Thoughts and What to Expect Next
As new developments continue to unfold, staying informed through reliable reporting remains essential. We will continue to follow any upcoming updates, official statements, and noteworthy news related to Serum Institute's large breakthrough in preventing pneumonia, prepared first indigenous vaccine. Check back regularly for the latest verified information.
Comments
No comments yet — be the first to share your thoughts.